Early Post Transplant Cardiac Allograft Vasculopathy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions

Cardiac Allograft Vasculopathy

Trial Locations (1)

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors

collaborator

Toronto General Hospital

OTHER

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT03217786 - Early Post Transplant Cardiac Allograft Vasculopathy | Biotech Hunter | Biotech Hunter